Herbal medicine is used worldwide either as a sole treatment method or as part of a comprehensive treatment plan alongside orthodox methods of diagnosis and treatment. A survey reported that, in the USA, nearly one-sixth of women took at least one herbal product in 2000. Despite their widespread use, numerous reports show that the herbal products available to consumers are of variable quality. This disparity in quality of herbal preparations can be attributed to the fact that their production is complicated. To produce high-quality herbal products, attention must be paid to, among others, phytochemical variations due to plant breed, organ specificity, stages of growth, cultivation parameters, contamination by microbial and chemical agents, substitution, adulteration with synthetic drugs, heavy metal contamination, storage and extraction. This review focuses on organ specificity, seasonal variations, the effect of drying and storage, and the extraction of phytochemical constituents. Special emphasis is placed on the four most frequently used herbal products in the USA: echinacea, Ginkgo biloba, ginseng and St John's Wort.

Ginseng (Panax ginseng, C.A. Meyer) has been a popular herbal remedy used in eastern Asian cultures for thousands of years. In North America, the ginseng species indigenous to both Canada and the United States (Panax quinquefolium) represents an important industry for both domestic and export markets. There are numerous theories and claims describing the efficacy of ginseng, which can combat stress, enhance both the central and immune systems and contribute towards maintaining optimal oxidative status against certain chronic disease states and aging. Risk issues concerning the safety of ginseng at recommended dosages are less prominent and scientifically based. While some epidemiological or clinical studies have reported indications of efficacy for specific health benefits or potential toxicity, there are an equal number of studies that provide contradictory evidence. This situation has led to questionable conclusions concerning specific health benefits or risks associated with ginseng. Recent advances in the development of standardized extracts for both Panax ginseng (G-115) and Panax quinquefolius (CNT-2000) have and will continue to assist in the assessment of efficacy and safety standards for ginseng products. This paper reviews the scientific literature and evidence for ginseng efficacy and safety derived mostly from in vitro and animal studies and places emphasis on the need for more randomized, double-blinded, placebo clinical studies that can provide unequivocal conclusions. An example of the efficacy and safety of ginseng is provided with the description of biological activity of a North American ginseng extract (NAGE), which includes illustrating mechanisms for antioxidant activity without prooxidant properties.

The results of two acute placebo-controlled, double-blind cross-over studies assessing the effect of Panax ginseng (G115) on blood glucose levels are reported. In study 1, thirty participants received three treatments: placebo; 200 mg G115; 400 mg G115. In study 2, twenty-seven participants received four treatments: placebo (0 mg ginseng and 30 mg saccharin); ginseng (200 mg ginseng and 30 mg saccharin); placebo–glucose (0 mg ginseng and 25 g oral glucose); ginseng–glucose (200 mg ginseng and 25 g oral glucose). Blood glucose levels were measured at baseline (at 09.00 hours after an overnight fast) and then 60, 90 (study 1 only) and 120 min post-dose. Both studies demonstrated that G115 alone significantly lowers fasting blood glucose levels. Conversely, in study 2 there was a significant drink × ginseng interaction suggesting opposing glycaemic effects of ginseng under fasting and raised blood glucose conditions. These data have implications for the use of ginseng in individuals with poor gluco-regulation.

Interest in the cultivation of goldenseal is increasing and this may have benefits for agriculture, human health, and conservation. To enable a better understanding of growing conditions, cultivation methods reported in the literature were reviewed, 21 natural goldenseal populations in the northern portion of its natural range in North America were described and analyzed in terms of population size and health, and 15 successful growers were interviewed on requirements for optimal cultivation. Growing conditions in the wild were compared to those reported in the cultivation literature. Summary of data from natural populations suggests goldenseal grows best in mixed hardwood forests, under 60–65% shade, in moist sandy loam soils high in organic matter, with pH 5.7 to 6.3. Similarly, review of the literature suggests that goldenseal grows best in moist, well-drained loams high in organic matter, with pH 5.5 to 6.5. Reported shade requirements vary but 47–80% shade is considered optimal. Growing conditions reported by growers were also consistent with the cultivation literature and similar to conditions of wild populations. Although optimal growing conditions are similar to those for many crops, goldenseal is relatively robust and can grow well in a variety of conditions including wet, predominantly sandy or clay soils with pH as low as 4.8 and as high as 7.8. Cultivation can utilize a ginseng crop infrastructure and goldenseal has been recommended as a rotation crop for ginseng. Commercial production of goldenseal is potentially advantageous because (1) it is an environmentally friendly crop; (2) it has been grown successfully far outside its natural range, is easy to grow, and is considered potentially profitable; and (3) it is relatively inexpensive, having low energy, land area, and fertilization requirements. Development of a sustainable crop may contribute to the protection of native wild germplasm, which can provide valuable material for crop improvement.